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1. INTRODUCTION 
 
The pretence to have a safety method for replacement of esophagus is 
coeval with esophagus-surgery. The results of the surgical treatment of 
esophageal atresia reveal that, if only a short defect is to be bridged end-to-end 
repair is possible without the risk of late re-stenosis. After the first successful 
antethoracal, gastric by-pass of esophagus (Jianu 1903.) several methods have 
been evaluated to by-pass or after a resection to replace the esophagus; so it 
means none of them is perfect, according to the late functional results. In the 
routine surgery stomach, jejunum or the large intestine can be used as a neo-
esophagus.  
In rare cases, the organ chosen to replace the esophageal defect is too 
short or unsuitable. During the past 50 years surgeons have long faced the 
problem of filling such an esophageal hiatus. Various prostheses, allografts 
and composite grafts have been evaluated, but with no real success to date. 
In my work, after the review of esophageal illnesses treated by 
replacement and its available methods, we have investigated whether the use 
of a tracheal graft could or could not be used successfully to replace the 
resected esophagus, and what kind of preparation could create from this organ 
an available neo-esophagus. 
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1.1.  OVERALL AIM OF THE PROJECTS 
 
 In the first phase of our research we would investigated whether 
cryopreserved animal trachea is suitable for the replacement of the 
esophagus. We observed the technical applicability of the operation, 
survive of animals, suitability of the graft and the postoperative 
complications. 
 
 In the second phase of our research using MHC-II. (MHC = major 
histocompatibility complex) antigen specific antibody-staining we have 
examined whether cryopreservation can reduce the antigenicity of the 
human trachea and, if so, the optimum duration of preservation.  
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2. FIRST PHASE OF THE EXPERIMENT: THE ANIMAL MODEL 
 
2.1 INTRODUCTION In this phase we would find a key for the rare cases, 
the intestine chosen for the replacement of the esophageal defect is too short, 
and only a couple of centimetres long artificial esophagus would be required in 
order to create a tensionless anastomosis. To fill the remaining hiatus tracheal 
allograft would have been used. Before the implantation the graft was 
cryopreserved to reduce the immunoreaction and to avoid rejection. The 
examination was based on observations of Japanese researchers, that 
cryoprecipitation of the trachea may result in the desquamation of inner 
epithelial layer causing decrease of its antigenity.  
 
2.2 MATERIALS AND METHODS Our experiments were performed in 12 
Beagle dogs (mean weight: 10.75 kg) under intramuscular narcosis. Following 
a median cervical incision, the appropriate muscles were dissected and a 6 cm-
long segment of the esophagus was removed, having been cut at 2 cm distal to 
the pharyngo-esophageal junction. For the replacement of the segment, from 
other Beagles a 6 cm long tracheal allograft was utilized with a mean internal 
diameter of 19mm (±1mm). The implant had been cryopreserved before the 
procedure for 21 days at -86°C. Cooling at a controlled rate was not applied; 
the samples were transferred into liquid nitrogen in one step. Water bath was 
used to warm up the cryopreserved tracheal segment to body temperature on 
the day of the operation. The end-to-end anastomosis was prepared using 
simple continuous suture (Biosyn® 3/0) and was covered with the sternohyoid 
flap. The procedure took 116 minutes to perform on average (90-150 minutes). 
All animals received intraoperative “single-shot” intravenous antibiotic 
prophylaxis. The dogs only received analgesics (metamizole i.m. 12 and 24 
hours following the operation) in the postoperative period; they did not receive 
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 any anti-inflammatory or immunosuppressive agents. All animals were fed 
parenterally for the first six postoperative days.  There was no nasogastric tube 
inserted. On day 7, oral fluid consumption was initiated. From day 14 they 
received pasty food, orally. Body temperature was recorded and wound toilette 
was performed on a daily basis for each animal. Blood samples were collected 
on the 1st, 3rd, 5th, 7th, 14th, 28th and 56th postoperative days to determine 
qualitative and quantitative blood counts, including red blood cell count and 
platelet counts, hematocrit, haemoglobin, size diversity of red blood cells and 
platelets, plasma fibrinogen concentration and various coagulation parameters. 
The dogs had been randomised into three groups and were accordingly 
sacrificed on day 28 (n=4), 42 ( n=4) or 56 (n=4). The tracheal graft along with 
the esophagus and the surrounding tissues was removed for further 
evaluations. During the air leak test, the esophagus was clamped using an 
“Akiyama clamp” at 3 cm distal to the graft  and a syringe was inserted into 
the pharynx, - this way apparently closing proximal end – and air was inflated 
into the submerged graft until it became entirely distended (28-30ml). By 
measuring the inner diameter of the tracheal lumen, we also calculated the 
degree of any possible stricture. Furthermore, tissue samples were fixed using 
10% neutral formalin and paraffin. Microscopic sections were treated with 
haematoxylin-eosin staining. 
 
2.3 RESULTS Survive: No complications were recorded in the animals 
during the postoperative period. No suture insufficiency or graft-rejection was 
observed and the oral feeding of the dogs was free of any complications. In 
two cases wound suppuration was found involving only the cutaneous and 
subcutaneous layers. The graft: Those grafts, left in place for 56 days 
shortened from 60mm to a mean length of 47 mm (±3mm). The sutures 
withstood to the air-probe with excellent results. In 56 days, the mean internal  
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diameter constricted from 19mm (±1mm) to 15.8mm on average (±0,6mm). 
Laboratory results: Laboratory parameters characteristic for inflammation 
were altered in accordance with the peri-operative stress: following a 
temporary increase in the early postoperative period, the measured variables 
returned to the control value on the 7th postoperative day. On day 14, the same 
variables were at the base-level. All other examined parameters were 
essentially unchanged during the study period. Histology:  Histological 
examination of the trachea prior to implantation revealed the disintegration of 
the inner epithelial layer. Histological examination revealed that the 
esophageal epithelium adhered to the neo-esophagus prepared from the trachea 
by the fourth week; the native columnar-epithelium of the trachea was not 
detectable in the graft. Inflammation and granulation were merely revealed in 
the suture-lines and diminished later on. Inflammation characterized by acute 
inflammatory cells was present around the tracheal cartilages and the 
disintegration of these cartilages was also observed. 
 
2.4 DISCUSSION This phase was accompanied by a good result; in dogs the 
use of cryopreserved trachea for replacement of a 5-6 cm esophageal segment 
seems to be a promising technique. 
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3. SECOND PHASE OF THE EXPERIMENT: 
CRYOPRESERVATION OF THE HUMAN TRACHEA  
 
3.1 INTRODUCTION In this phase of our research we have examined 
whether cryopreservation can reduce the antigenicity of the human trachea 
and, if so, the optimum duration of preservation. 
 
3.2 MATERIALS AND METHODS During tracheostomy, segments of the 
tracheal wall were removed from 50 patients (mean age: 55 years (19-85), 34 
males/16 females). These segments, which contained all the tracheal layers, 
were removed with scissors; bipolar scissors were not used in order to avoid 
thermic lesions. In this part of the trachea, the intubational cuff was not 
pumped up, which might have caused compression injuries. The removed 
segments were free of inflammation or malignancy, as confirmed by 
histopathological examinations. They were divided into 4 parts. One part was 
placed in formalin and histopathological examinations were performed 
immediately (Group 1). The other 3 parts were stored in liquid nitrogen for 2 
(Group 2), 3 (Group 3) or 4 weeks (Group 4). Cooling at a controlled rate was 
not applied; the samples were transferred into liquid nitrogen in one step. After 
the subsequent warm-up, microscopic sections were subjected to staining with 
haematoxylin-eosin and MHC-II antigen-specific antibody. During the 
evaluation, the intensity of staining was graded on a scale of from 0 to 3+. 
After this grading, the mean intensity of staining and its standard deviation 
were calculated by using the Student T-test. All experiments were carried out 
in full accordance with the relevant Hungarian legal and ethical requirements, 
and all the involved patients gave their signed informed consent. 
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3.3 RESULTS Four of the 50 trachea segments could not be evaluated 
histologically, because the preparation did not contain sufficient epithelium for 
the examination. Accordingly, 46x4 (184) parts from 46 samples were worked 
up statistically. HE staining demonstrated that there was no desquamation of 
the respiratory epithelium after cryopreservation. The MHC-II antibodies were 
mostly situated in the apical part of the epithelial cells. The mean intensity of 
staining was 1.5+ – 1.9+ with a decreasing tendency, but the intergroup 
differences were not significant. 
 
3.4 DISCUSSION The cryopreservation of the human trachea does not cause 
epithelial desquamation from the inner surface. The mean intensity of MHC-II 
staining decreased not significantly, so independently of its duration this 
method does not cause a significant reduction in the antigenicity of human 
trachea.  
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4. OVERALL DISCUSSION  
 
The aim of our research was to find an applicable method to replace the 
esophagus by using an extraintestinal tissue. 
 When segment resection is necessary for the treatment of esophageal 
diseases, resection and reconstruction are the consecutive steps of the operative 
plan. Primary reconstruction, with end-to-end anastomosis is only feasible in 
case of a short defect. In case of a more extensive hiatus, esophageal 
replacement is the method of choice. In rare cases, the conventional organs 
(stomach, jejunum, large intestine) for replacement are not feasible. Various 
methods and materials have been evaluated to bridge this gap, with no real 
success to date. 
We would investigate whether the trachea could be used to replace a short 
segment of esophagus. 
Anatomically, the trachea is an organ with scant blood-supply: its 
cartilagous portion is avascular, would be an ideal organ for the replacement. 
Over the last 20 years several researchers have developed experimental models 
for tracheal replacement using allogenous trachea segments. According to 
these observations, the transplant receives its nutritive supply mainly from 
blood vessels emerging from the anastomoses following the implantation. This 
might serve as the principal reason why the length of the safety implantable 
trachea segment is limited to 5-6 cm; otherwise necrosis is likely to develop in 
the middle part of the graft. Confirming the results of the Japanese authors, 
those factors principally responsible for antigenecity and thus for graft 
rejection seem to be located on the inner epithelial layer of the trachea. 
Epithelial desquamation, caused by cryopreservation, may result in the loss of 
antigenity. In our animal experiments the cryopreservation was used  
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exclusively; and the trachea transplantation was completed following the 
cryopreservation of the graft. Histological examination revealed that the graft 
incorporated normally into the body. According to our data in vivo, the trachea 
seems to be a feasible organ for the replacement of a 5-6 cm oesophageal 
segment, and the 21-day-long cryopreservation alone seems to be enough to 
reduce the antigenecity of the organ and to prevent its rejection. 
In the next phase we have examined whether this method could be 
applicable in the human treatment too and the cryopreservation could reduce 
the antigenicity of the human trachea. The results were contrary to our 
expectations, cryopreservation of the human trachea does not cause 
desquamation of the inner surface and accordingly there is no significant 
decrease in the intensity of immunological staining. Independently of its 
duration, cryopreservation alone is not sufficient to allow use of the human 
trachea as an allograft.  
Anatomically the trachea seemed to be available to create a neo-
esophagus, so we thought this aim had justification. If the result had been 
positive, a “trachea-bank” would have been created from cryopreserved 
organs. But we can conclude that, the cryopreservation of the trachea gave us 
not the expected result. 
 
In the following research we would investigate the reason of the different 
immunological behaviour of animal and human trachea. During the 
cryopreservation we would apply cooling at a controlled rate or cryoprotective 
agent. After this phase the problem seems to be not surgical, the key can be in 
the development of immunosuppressive medication, or in the research of stem-
cells. Maybe an artificial neo-esophagus will be created from pluripotent cells 
in the future. 
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5.  NOVEL FINDINGS 
 
 In animal models we have verified that the 21-day-long cryopreservation 
of the trachea can cause epithelial desquamation on the inner surface, so 
cryopreservation alone seems to be enough to reduce the antigenecity of 
the organ and to prevent its rejection. 
 
 In dogs the cryopreservated trachea seems to be a feasible organ for the 
replacement of a 5-6 cm oesophageal segment, the organ can completely 
incorporate by the fourth week into the recipient body, the esophageal 
epithelium adheres to the neo-esophagus.  
 
 Cryopreservation of the human trachea does not cause desquamation of 
the epithelial layer; this preparation can decrease the antigenecity of the 
organ, but the tendency is not significant. So we can conclude that 
cryopreservation alone is not sufficient to allow use of the human trachea 
as an allograft. 
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